ARTICLE | Distillery Therapeutics
Infectious disease
June 27, 2017 4:06 PM UTC
Cell culture and mouse studies suggest inhibiting ZNRF1 could help treat sepsis. In lipopolysaccharide (LPS)-treated human and mouse macrophage cell lines, knockdown of ZNRF1 decreased levels of infla...
BCIQ Company Profiles
BCIQ Target Profiles